DCPH - Deciphera Pharmaceuticals GAAP EPS of -$1.51 misses by $0.03 revenue of $24.2M beats by $0.92M February, 08 2022 04:20 PM Deciphera Pharmaceuticals Inc. Deciphera Pharmaceuticals press release (NASDAQ:DCPH): Q4 GAAP EPS of -$1.51 misses by $0.03. Revenue of $24.2M (+24.2% Y/Y) beats by $0.92M. For further details see: Deciphera Pharmaceuticals GAAP EPS of -$1.51 misses by $0.03, revenue of $24.2M beats by $0.92M